NCT05176145View on ClinicalTrials.gov

Demonstration of the Medical Interest of the VisioCyt® Artificial Intelligence Test

NARecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

April 5, 2022

Primary Completion Date

February 1, 2025

Study Completion Date

May 31, 2025

Conditions
Non-muscle Invasive Bladder Cancer (NMIBC)
Interventions
DEVICE

VisioCyt®

"* Cytological and endoscopic examination is planned as part of the usual management of patients under surveillance of Non-muscle invasive bladder cancer (NMIBC), according to the CCAFU guidelines.~* Urine collection for conventional cytology and VisioCyt® test"

Trial Locations (15)

1070

RECRUITING

Hôpital Académique ERASME, Anderlecht

14000

RECRUITING

CHU de Caen, Caen

31130

RECRUITING

Clinique la Croix du Sud, Quint-Fonsegrives

63003

RECRUITING

CHU de Clermont Ferrand, Clermont-Ferrand

Unknown

RECRUITING

CHU Angers, Angers

RECRUITING

CHU Grenoble, Grenoble

RECRUITING

CHU Nantes, Nantes

RECRUITING

Hôpital Bichat-Claude Bernard,, Paris

RECRUITING

Hôpital Pitié-Salpétrière, APHP, Paris

RECRUITING

CHU de Rennes, Rennes

RECRUITING

CHU Strasbourg, Strasbourg

RECRUITING

Hopital Foch, Suresnes

RECRUITING

CHU Toulouse, Toulouse

RECRUITING

CHU Tours, Tours

RECRUITING

Pr Maria Jose Ribal, Barcelona

All Listed Sponsors
collaborator

FONDATION FORCE POUR L'INNOVATION ET LA RECHERCHE EN SANTE

UNKNOWN

lead

Vitadx

OTHER